Is Carafate (sucralfate) safe to use during breastfeeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Carafate (Sucralfate) and Breastfeeding

Carafate (sucralfate) is safe to use during breastfeeding, as it has minimal systemic absorption and is unlikely to be excreted into breast milk in clinically significant amounts.

Primary Evidence from FDA Labeling

The FDA label for sucralfate states that "it is not known whether this drug is excreted in human milk" and recommends that "caution should be exercised when sucralfate is administered to a nursing woman" 1. However, this conservative language reflects the lack of formal studies rather than evidence of harm.

Clinical Rationale for Safety

The pharmacologic properties of sucralfate make it one of the safest gastrointestinal medications during breastfeeding:

  • Sucralfate acts locally in the gastrointestinal tract with minimal systemic absorption, meaning very little drug enters the maternal bloodstream to potentially transfer into breast milk 2

  • For reflux disease during lactation, sucralfate is specifically preferred because it has minimal systemic absorption compared to other agents 2

  • Drugs with poor systemic absorption are considered first-line therapy for gastrointestinal conditions in breastfeeding mothers, as they pose negligible risk to the infant 3

Practical Considerations

  • The dose of most drugs transferred into milk is small and does not lead to clinically significant effects on the infant 4

  • Medications that are not absorbed systemically should be considered first-line therapy for gastrointestinal conditions during breastfeeding 3

  • You can continue breastfeeding without interruption while taking sucralfate 2

Common Pitfalls to Avoid

  • Do not confuse the FDA's cautionary language with actual evidence of harm—the statement reflects lack of formal lactation studies, not documented toxicity 1

  • Do not unnecessarily discontinue breastfeeding, as the substantial benefits of breastfeeding for both infant and maternal health outweigh theoretical minimal drug exposure 5

  • Be aware that most commonly used drugs are relatively safe for breastfed babies, with the dose received via milk being generally small and much less than known safe doses given directly to infants 6

References

Research

Treatment of reflux disease during pregnancy and lactation.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2017

Research

Gastrointestinal medications and breastfeeding.

Journal of human lactation : official journal of International Lactation Consultant Association, 1998

Guideline

Mucinex Safety During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drugs in breastfeeding.

Australian prescriber, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.